Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-r4mrb Total loading time: 0 Render date: 2025-03-12T06:08:26.026Z Has data issue: false hasContentIssue false

Chapter 32 - Psychiatric Care of the Medical Patient

Neuroleptic Malignant Syndrome and Serotonin Syndrome

Published online by Cambridge University Press:  02 January 2025

By
Lindsey S. Pershern  and
Robert J. Boland
Edited by
Marsal Sanches  and
Jair C. Soares
Marsal Sanches
Affiliation:
McGovern Medical School, Texas
Jair C. Soares
Affiliation:
McGovern Medical School, Texas
Get access

Summary

Psychiatrists are often called to see nonpsychiatric patients in medical settings. Two potential reasons for a consult are neuroleptic malignant syndrome and serotonin syndrome; both are potential emergencies. They differ in cause and pathophysiology. However, they have certain things in common: Both are rare and may go unrecognized or misdiagnosed. In addition, the course of both syndromes depends on the speed of intervention, and delays can result in lasting complications or mortality. This chapter reviews the features of each syndrome, the diagnosis and differential, and the recommended treatment approaches.

Keywords

Antipsychotic agentsBasal Ganglia DiseasesChemically Induced DisordersDopamineDrug-Related Side Effects and Adverse ReactionsNeuroleptic Malignant SyndromeNeurotoxicity SyndromesSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Syndrome
Type
Chapter
Information
Fundamentals of Clinical Psychiatry
A Practical Handbook
 , pp. 326 - 338
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ayd, FJ. Fatal hyperpyrexia during chlorpromazine therapy. J Clin Exp Psychopathol 1956; 17: 189–192.Google ScholarPubMed
Delay, J, Pichot, P, Lemperiere, T, et al. [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses]. Ann Med Psychol (Paris) 1960; 118(1): 145–152.Google Scholar
Berman, BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist 2011; 1: 41–47.CrossRefGoogle ScholarPubMed
Gurrera, RJ. A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency. Acta Psychiatr Scand 2017; 135: 398–408.CrossRefGoogle ScholarPubMed
Schneider, M, Regente, J, Greiner, T, et al. Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993–2015. Eur Arch Psychiatry Clin Neurosci 2020; 270: 23–33.CrossRefGoogle ScholarPubMed
Guinart, D, Misawa, F, Rubio, JM, et al. A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome. Acta Psychiatr Scand 2021; 144: 329–341.CrossRefGoogle ScholarPubMed
Misawa, F, Okumura, Y, Takeuchi, Y, et al. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan. Schizophr Res 2021; 231: 42–46.CrossRefGoogle ScholarPubMed
Funayama, M, Takata, T, Koreki, A, et al. Catatonic stupor in schizophrenic disorders and subsequent medical complications and mortality. Psychosom Med 2018; 80: 370–376.CrossRefGoogle ScholarPubMed
Ueda, M, Hamamoto, M, Nagayama, H, et al. Biochemical alterations during medication withdrawal in Parkinson’s disease with and without neuroleptic malignant-like syndrome. J Neurol Neurosurg Psychiatry 2001; 71: 111–113.CrossRefGoogle ScholarPubMed
Gurrera, RJ. Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia? Clin Neuropharmacol 2002; 25: 183–193.CrossRefGoogle ScholarPubMed
Ortiz, JF, Wirth, M, Eskander, N, et al. The genetic foundations of serotonin syndrome, neuroleptic malignant syndrome, and malignant hyperthermia: is there a genetic association between these disorders? Cureus 2020; 12: e10635.Google Scholar
Kuhlwilm, L, Schönfeldt-Lecuona, C, Gahr, M, et al. The neuroleptic malignant syndrome: a systematic case series analysis focusing on therapy regimes and outcome. Acta Psychiatr Scand 2020; 142: 233–241.CrossRefGoogle Scholar
PDR.net. Dantrium Capsules (dantrolene sodium) dose, indications, adverse effects, interactions… from PDR.net, www.pdr.net/drug-summary/Dantrium-Capsules-dantrolene-sodium-1213 (accessed February 15, 2023).Google Scholar
PDR.net. Parlodel (bromocriptine mesylate) dose, indications, adverse effects, interactions… from PDR.net, www.pdr.net/drug-summary/Parlodel-bromocriptine-mesylate-1808.330 (accessed February 15, 2023).Google Scholar
PDR.net. Amantadine Hydrochloride Capsules (amantadine hydrochloride) dose, indications, adverse effects, interactions… from PDR.net, www.pdr.net/drug-summary/Amantadine-Hydrochloride-Capsules-amantadine-hydrochloride-1475 (accessed February 15, 2023).Google Scholar
Rajan, R, Sage, M. Successful emergency treatment of refractory neuroleptic malignant syndrome with electroconvulsive therapy and a novel use of dexmedetomidine: a case report from California in the era of COVID-19. J ECT 2021; 37: 71–73.CrossRefGoogle Scholar
Tao, M, Li, J, Wang, X, et al. Malignant syndromes: current advances. Expert Opin Drug Saf 2021; 20: 1075–1085.CrossRefGoogle ScholarPubMed
Scotton, WJ, Hill, LJ, Williams, AC, Barnes, NM. Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions. Int J Tryptophian Res 2019; 12: 1–14.Google ScholarPubMed
Sparado, A, Scott, KR, Koyfman, A, Long, B. High risk and low prevalence diseases: aerotonin syndrome. Am J Em Med 2022; 61: 90–97.Google Scholar
Foong, A, Grindrod, KA, Patel, T, Kellar, J. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician 2018; 64(10): 720–727.Google ScholarPubMed
Boyer, EW, Shannon, M. The serotonin syndrome. N E J Med 2005; 352(11): 1112–1120.CrossRefGoogle ScholarPubMed
Levenson, JL. Textbook of Psychosomatic Medicine and Consultation: Liaison Psychiatry. 3rd ed. American Psychiatric Association Publishing; 2019.Google Scholar
Ables, AZ, Nagubilli, R. Prevention, diagnosis and management of serotonin syndrome. Am Fam Physician 2010; 81(9): 1139–1142.Google ScholarPubMed
Werneke, U, Truedson-Martiniussen, P, Wikström, H, Ott, M. Serotonin syndrome: a clinical review of current controversies. J Integrat Neurosci 2020; 19(4): 719–727.CrossRefGoogle ScholarPubMed
Prakash, S, Rathore, C, Rana, K, Prakash, A. Fatal serotonin syndrome: a systematic review of 56 cases in the literature. Clin Toxicol 2020; 59(2): 89–100.CrossRefGoogle ScholarPubMed
Dunkley, EJ, Isbister, GK, Sibbritt, D, Dawson, AH, Whyte, IM. The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635–642.CrossRefGoogle ScholarPubMed
Radomski, JW, Dursun, SM, Reveley, MA, Kutcher, SP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Medical Hypotheses. 2000; 55: 218–224CrossRefGoogle Scholar
Sternbach, H. The serotonin syndrome. Am J Psychiatry 1991; 148(6): 705–713.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×